The Maudsley Prescribing Guidelines in Psychiatry Paperback – April 2, 2012
Author: Visit Amazon's David Taylor Page | Language: English | ISBN: 0470979488 | Format: PDF, EPUB
Download electronic versions of selected books The Maudsley Prescribing Guidelines in Psychiatry Paperback – April 2, 2012 for everyone book 4shared, mediafire, hotfile, and mirror link
Review
“This comprehensive guide presents clinicians with evidence-based information on prescribing psychotropic drugs for mental health … This book will help nurses to be confident, sensitive and informed when discussing medication with patients and relatives, exploring treatment options within their professional teams and liaising with allied health professionals.” (Nursing Standard, 30 May 2012)
From the Back Cover
This book is the essential guide for anyone responsible for prescribing, dispensing or
administering drugs for patients with mental health disorders. All the evidence has been
reviewed and summarised succinctly by an expert team of psychiatrists and pharmacists.
The evidence base for drug treatments in psychiatry ranges from meta-analyses and
randomised controlled clinical trials to single case reports, from NICE guidelines to
individual SPCs. Where to look for information when transferring a patient from one
drug to another or when dealing with a complex patient (for example, with co-morbid
epilepsy or liver disease or HIV infection)? The Maudsley Prescribing Guidelines are
established as the leading clinical relevant reference for handling complex prescribing
problems and for formulating prescribing policy.
This new edition makes greater use of tables and boxes to facilitate quick reference and
includes new sections on cytochrome-mediated interactions, psychiatric side effects of
non-psychotropic drugs and on GBL and GHB dependence.
Chapters cover plasma monitoring, schizophrenia, bipolar disorder, depression and
anxiety, children and adolescents, substance misuse and special patient groups. Each
section has a full reference list. The book covers prescribing drugs outside their licensed
indications and their interaction with substances such as alcohol, nicotine and caffeine.
Trainees will gain important information regarding the rational, safe and effective use
of medications for patients with mental illness. Experienced clinicians will find excellent
guidance regarding more complex issues that they may not encounter regularly.
Praise for previous editions:
“I would regard this book as mandatory for any pharmacist directly involved in the
care of patients with a psychiatric diagnosis, be they primary or secondary care-based.”
The Pharmaceutical Journal
“An excellent book and a ‘must’ for practising psychiatrists… not only will the rational
prescribing of psychotropic drugs drastically improve but, more importantly, the
patient will certainly benefit.”
Human Psychopharmacology
Books with free ebook downloads available The Maudsley Prescribing Guidelines in Psychiatry – April 2, 2012
- Paperback: 680 pages
- Publisher: Wiley-Blackwell; 11 edition (April 2, 2012)
- Language: English
- ISBN-10: 0470979488
- ISBN-13: 978-0470979488
- Product Dimensions: 8.3 x 7.1 x 1.2 inches
- Shipping Weight: 2.2 pounds (View shipping rates and policies)
- Amazon Best Sellers Rank: #44,140 in Books (See Top 100 in Books)
- #4 in Books > Medical Books > Pharmacology > Clinical
- #15 in Books > Medical Books > Psychology > Psychopharmacology
- #17 in Books > Health, Fitness & Dieting > Psychology & Counseling > Psychopharmacology
Acknowledgements x
Notes on using The Maudsley Prescribing Guidelines xi
Notes on inclusion of drugs xi
List of abbreviations xii
Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants 1
Interpreting sample results 2
Chapter 2 Schizophrenia 11
Antipsychotic drugs 11
Antipsychotic drugs: equivalent doses 13
Antipsychotic drugs: minimum effective doses 14
Antipsychotic drugs: licensed maximum doses 16
New antipsychotic drugs 17
Antipsychotic drugs: general principles of prescribing 21
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia 22
Treatment algorithms for schizophrenia 24
Antipsychotic drugs: monitoring of metabolic effects 26
Switching antipsychotic drugs because of poor tolerability 31
Antipsychotic response: to increase the dose, to switch, to add or just wait – what is the right move? 33
Speed and onset of antipsychotic drug action 36
First-generation antipsychotic drugs: place in therapy 39
Antipsychotic drugs: long-acting injections 40
Risperidone long-acting injection 44
Paliperidone palmitate long-acting injection 47
Management of patients on long-term depots: dose reduction 50
Combined antipsychotic drugs 51
High-dose antipsychotic drugs: prescribing and monitoring 54
Negative symptoms in schizophrenia 57
Antipsychotic prophylaxis 60
Refractory schizophrenia and clozapine 64
Clozapine augmentation 66
Refractory schizophrenia: alternatives to clozapine 69
Clozapine: management of common adverse effects 75
Clozapine: uncommon or unusual adverse effects 78
Clozapine: serious haematological and cardiovascular adverse effects 80
Clozapine, neutropenia and lithium 84
Clozapine and chemotherapy 88
Clozapine-related hypersalivation 89
Guidelines for the initiation of clozapine for patients based in the community 92
Omega-3 fatty acids (fish oils) in schizophrenia 96
Extrapyramidal side-effects of antipsychotic drug treatment 98
Treatment of antipsychotic-induced akathisia 103
Treatment of tardive dyskinesia 105
Neuroleptic malignant syndrome 110
Catatonia 113
Cardiovascular effects of antipsychotic drug treatment 115
Antipsychotic drugs and hypertension 122
Hyperprolactinaemia 123
Antipsychotic-induced weight gain 126
Treatment of drug-induced weight gain 128
Antipsychotic drugs, diabetes and impaired glucose tolerance 132
Antipsychotic drugs and dyslipidaemia 138
Antipsychotic drugs and sexual dysfunction 142
Antipsychotic-associated hyponatraemia 148
Antipsychotics and pneumonia 150
Relative adverse effects of antipsychotic drugs: a rough guide 151
Chapter 3 Bipolar disorder 153
Valproate 153
Lithium 159
Carbamazepine 168
Physical monitoring of people with bipolar disorder 173
Treatment of acute mania or hypomania 176
Antipsychotic drugs in bipolar disorder 182
Bipolar depression 185
Rapid cycling bipolar disorder 191
Prophylaxis in bipolar disorder 193
Chapter 4 Depression and anxiety 197
Depression 197
Antidepressants 201
Treatment of resistant depression 222
Treatment of psychotic depression 233
Electroconvulsive therapy and psychotropic drugs 235
Psychostimulants in depression 239
Treatment of depression in the elderly 243
Treatment of depression in stroke 247
Adverse effects of antidepressants 249
Selective serotonin reuptake inhibitors and bleeding 252
Depression and diabetes 255
Cardiac effects of antidepressants 257
Antidepressants and sexual dysfunction 264
Antidepressants and hyperprolactinaemia 268
Antidepressants: swapping and stopping 270
St John’s wort in the treatment of depression 278
Drug interactions with antidepressants 281
Alternative routes of administration for antidepressants 286
Anxiety spectrum disorders 292
Benzodiazepines in the treatment of psychiatric disorders 301
Benzodiazepines and disinhibition 304
Benzodiazepines: dependence and detoxification 306
Insomnia 310
Chapter 5 Children and adolescents 315
Principles of prescribing practice in childhood and adolescence 315
Depression in children and adolescents 316
Bipolar illness in children and adolescents 321
Psychosis in children and adolescents 326
Anxiety in children and adolescents 327
Obsessive compulsive disorder in children and adolescents 328
Attention deficit hyperactivity disorder 332
Autism spectrum disorders 337
Tics and Tourette’s syndrome 345
Melatonin in the treatment of insomnia in children and adolescents 349
Rapid tranquillisation in children and adolescents 351
Doses of commonly used psychotropic drugs in children and adolescents 354
Chapter 6 Substance misuse 355
Alcohol dependence 356
Opioid misuse and dependence 372
Nicotine and smoking cessation 398
Stimulant drugs of dependence 406
Benzodiazepine misuse 407
-Butaryl-lactone and -hydroxybutyrate dependence 408
Drugs of misuse: a summary 410
Interactions between ‘street drugs’ and prescribed psychotropic drugs 414
Chapter 7 Use of psychotropic drugs in special patient groups 419
Epilepsy 419
Pregnancy 430
Breast feeding 446
Renal impairment 462
Hepatic impairment 478
Prescribing in the elderly 487
Dementia 490
Behavioural and psychological symptoms of dementia 509
Parkinson’s disease 518
Multiple sclerosis 522
Eating disorders 527
Acutely disturbed or violent behaviour 531
Psychotropic medications for adults with learning disabilities 539
Borderline personality disorder 545
Delirium 547
Huntington’s disease 554
Psychotropic drugs and surgery 558
Prescribing psychotropic drugs for patients with HIV infection 564
Psychotropic drugs and cytochrome (CYP) function 573
Summary of psychiatric side-effects of non-psychotropic drugs 578
Chapter 8 Miscellaneous conditions and substances 587
Psychotropic drugs in overdose 587
Biochemical and haematological effects of psychotropic drugs 593
Prescribing drugs outside their licensed indications 604
Observations on the placebo effect in mental illness 606
Drug interactions with alcohol 608
Nicotine 613
Smoking and psychotropic drugs 616
Caffeine 618
Complementary therapies 624
Enhancing medication adherence 628
Driving and psychotropic medicines 634
Covert administration of medicines within food and drink 643
Index 647
No comments:
Post a Comment